CAR-T Cell Therapy: Apheresis

Mayo Clinic pathologist, Dr. Jefferey Winters, explains what apheresis is, how it is done, and why it used for a patient undergoing chimeric antigen receptor T cell therapy (CAR-T cell therapy).
Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to recognize and destroy certain cancers. Learn more: mayocl.in/2JdrlO2.